Advocacy

Patient Advocacy Using our experience and expertise in facilitating access to medicine, we help support the efforts patient advocacy groups around the world. We recognize the outstanding work that these groups do and are committed [...]

By |2024-11-19T16:55:15+00:00November 12th, 2024|

Modern Slavery Statement

WEP Modern Slavery Statement OUR POLICY At WEP Clinical, we are fully committed to conducting business with integrity and upholding ethical standards across all aspects of our operations. We prioritize the implementation of robust [...]

By |2024-10-30T16:27:46+00:00October 30th, 2024|

WEP 3PL

WEP 3PL Operating as a global distributor, WEP Clinical possess the in-house capabilities to provide end-to-end third party logistics (3PL) & supply chain solutions to the pharmaceutical industry.Finding the right 3PL provider is critical to the [...]

By |2024-11-14T09:35:49+00:00October 30th, 2024|

Post-Trial Access

Post-Trial Access Post-trial access (PTA) allows Sponsors to provide access to their investigational drugs for patients after the clinical trial has ended.What options exist at the end of your trial for continued drug supply to [...]

By |2024-11-14T13:18:19+00:00October 21st, 2024|

WEP Insights

WEP Insights The WEP team is made up of industry leaders with expert knowledge and experience working in clinical trials, access programs, and market access strategies. Learn more from our Subject Matter Experts (SMEs) on [...]

By |2024-10-24T15:22:17+01:00October 8th, 2024|

Booking Form 22.10

BioBites and Beverages Join Us for an Exclusive Industry Gathering! WEP invites you to an evening of insights and connections at our Happy Hour event. This is your chance to engage with WEP key [...]

By |2024-09-19T19:45:27+01:00September 16th, 2024|

Project Management

Project Management At WEP, we are dedicated to delivering operational excellence through our robust project management. Our PMs integrate seamlessly with your team, offering customized solutions, data-driven decisions, expert oversight, and seamless execution. We are [...]

By |2024-11-19T12:58:01+00:00August 2nd, 2024|
Go to Top